Loading provider…
Loading provider…
Hematology & Oncology Physician in Bethesda, MD
NPI: 1356302095HQ Phone
Get MD Charles's Phone Numberphone_androidMobile
Get MD Charles's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
DC State Medical License
DC State Medical License
2012 - 2027
NY State Medical License
1987 - 2025
MD State Medical License
2006 - 2016
NJ State Medical License
2005 - 2007
College of Physicians and Surgeons of Columbia University
1986 - 1989
New York Presbyterian Hospital (Columbia Campus)
Fellowship • Hematology and Medical Oncology
Until 1989
Johannesburg Hospital
Internship Residency
1979 - 1986
Johannesburg Teaching Hospitals
Chief Residency • 1984 - 1984
1984 - 1984
Residency • 1981 - 1983
1981 - 1983
Internship • 1979 - 1979
1979 - 1979
University of the Witwatersrand
Medical School
Until 1978
Authors: Gerald Appel
Journal: Am J Nephrol
Thymic Stromal Lymphopoietin is a key mediator of breast cancer progression.
Authors: Olkhanud, Purevdorj B, Rochman, Yrina, Bodogai, Monica, Malchinkhuu, Enkhzol, Wejksza, Katarzyna, Xu, Mai, Gress, Ronald E, Hesdorffer, Charles, Leonard, Warren J, Biragyn, Arya
Journal: J Immunol
Publication Date: 2011-04-13
Lead Sponsor: National Institute on Aging (NIA)
Intervention / Treatment: PROCEDURE: Muscle Biopsy
Lead Sponsor: Herbert Irving Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: filgrastim, PROCEDURE: peripheral blood stem cell transplantation, DRUG: cyclophosphamide, BIOLOGICAL: sargramostim, BIOLOGICAL: recombinant interferon alfa, DRUG: melphalan, PROCEDURE: bone marrow ablation with stem cell support, PROCEDURE: autologous bone marrow transplantation, DRUG: busulfan
Lead Sponsor: Herbert Irving Comprehensive Cancer Center
Intervention / Treatment: DRUG: Melphalan, PROCEDURE: Autologous Stem Cell Transplantation